Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of Mycobacterium tuberculosis H37Rv treated with alpibectir or a combination of alpibectir and ethionamide against untreated controls

ABSTRACT: Alpibectir potentiates the activity of ethionamide and prothionamide, which are second-line antibiotics used for tuberculosis treatment. Both are prodrugs whose antibacterial activity depends on bioactivation by oxidases, including the Baeyer-Villiger monooxygenase MymA. Alpibectir binds the transcriptional regulator VirS, increasing MymA expression and potentiating Eto and Pto activity. To determine the transcriptional response of M. tuberculosis to alpibectir, we treated cultures at an optical density of 0.7 with alpibectir 0.1 mg/L for 24 h. Alternatively, we determined the transcriptional response of cultures first treated with alpibectir 0.1 mg/L for 20 h followed by ethionamide 2 mg/L for 4 h. Untreated controls (DMSO 0.1%) were included.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Mycobacterium tuberculosis

SUBMITTER: Zainab Edoo

PROVIDER: E-MTAB-16253 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Exposure of a bovine rumen microbiome model to glyphosate

Project description:We evaluated the effects of pure glyphosate and the formulations Durano TF and Roundup® LB plus in different concentrations on rumen microbiota bioreactor model using the Rumen Simulation Technique (RUSITEC). Application of the compounds in three concentrations (0.1 mg/L, 1.0 mg/L or 10 mg/L, n = 4 each).

2022-05-08 | PXD032166 | Pride

Comparison of mid-log transcriptomes of clinical isolates of Mycobacterium tuberculosis

Project description:The global diversity of Mycobacterium tuberculosis comprises at least seven lineages, each with its distinct geographic distribution. The aim of this experiment was to perform a comparative analysis of two of these lineages: Lineage 1 and Lineage 2. The former is found around the rim of the Indian ocean and in south-east Asia, while the latter is widely spread throughout Asia and shows an increasing global spread. We have chosen three fully drug susceptible clincal isolates to represent each of the two lineages. We performed RNAseq analysis on rRNA depleted samples isolated from cultures during mid-log phase. Each strain was measured in triplicate.

2020-12-31 | E-MTAB-8103 | biostudies-arrayexpress

Identifying the fitness cost of rifampicin-resistance in Mycobacterium tuberculosis through RNAseq profiling.

Project description:The experiment was designed to infer the fitness cost of rifampicin-resistance in Mycobacterium tuberculosis through expression analysis. The approach relied on: 1. Tracking the expression changes occurring as a result of the rifampicin-resistance conferring mutation Ser450Leu in RpoB and subsequent gain of compensatory mutation Leu516Pro in RpoC. The hypothesis was that any cost-incurring expressional changes would be reversed in the presence of compensatory mutations. The strains in this set were described before here: PMID 22179134. 2. Comparing the impact of the same rifampicin-resistance mutation (RpoB Ser450Leu) in five different genetic backgrounds. Here the comparison was solely between RpoB Ser450Leu and their cognate drug susceptible wild type ancestor. One of the strain pairs is the same as in point 1. above.

2018-11-18 | E-MTAB-7359 | biostudies-arrayexpress

RNA-seq and genome-wide CRISPRi and Tn-seq analyses of BVL3572S-treated Mycobacterium tuberculosis H37Rv

Project description:(i) RNA-seq of M. tuberculosis H37Rv cultures grown in the presence of BVL3572S for 6 h compared to untreated controls. (ii) Genome-wide M. tuberculosis H37Rv CRISPRi libraries were grown in the presence of ATc for 5 days prior to drug exposure. Cultures were treated with sub-MIC BVL3572S concentrations without amino acid or in the presence of L-His, L-Ala, or both. After 14 days outgrowth, genomic DNA were harvested from cultures for which BVL3572S concentrations were partially growth inhibitory and from untreated controls. Abundance of sgRNA was analyzed by deep sequencing. (iii) Genome-wide M. tuberculosis H37Rv transposon mutant librairies were treated with BVL3572S or untreated for 15 days followed by a 7-day antibiotic-free outgrowth. Genomic DNA were extracted, indexed, and sequenced.

2026-04-20 | E-MTAB-16773 | biostudies-arrayexpress

Mode of action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus

Project description:Screening of various bisquaternary bisnaphthalimides against a variety of human pathogens revealed one compound, designated MT02, with strong inhibitory effects against gram-positive bacteria. The minimal inhibitory concentrations ranged from 0.31 µg/ml against community-acquired methicillin resistant Staphylococcus aureus (MRSA) strain USA300 to 20 µg/ml against Streptococcus pneumonia. DNA-microarray studies generated a transcriptional signature characterized by a strong increase of genes involved in DNA-metabolism, DNA-replication, SOS-response and transport of positively charged compounds. Radioactive whole cell labeling experiments indicated a strong impact of MT02 on bacterial DNA-replication. Furthermore, surface plasmon resonance and gel retardation experiments demonstrated direct binding of MT02 to DNA in a concentration dependent, reversible and sequence-unspecific manner. The data presented suggest that the bisquaternary bisnaphthalimide MT02 exerts anti-gram-positive activity by binding to DNA and thereby prohibiting appropriate DNA-replication. WT strain exposed to MT02 for 60 minutes in rich medium

2011-01-04 | E-GEOD-23077 | biostudies-arrayexpress

Metabolic modeling of antibiotic and cytotoxic effects of the isoquinoline IQ-238 in S. aureus, S. epidermidis and human cells

Project description:Isoquinolines (IQs) are natural substances with antibiotic potential. IQ-238 is a synthetic analog of the novel-type N,C-coupled naphtylisoquinoline (NIQ) alkaloid ancisheynine. Gene expression data, cytotoxicity measurements and metabolic modelling is combined to assess the effects of the N,C-coupled naphtylisoquinoline (NIQ) compound IQ-238 on Staphylococcus aureus and man as a potential lead for novel antibiotics. It possesses a high activity against staphylococci but has low cytotoxicity in human cell lines. Genome annotation identified missed enzymes (validated by PCR) in the primary (e.g. nucleotide) metabolism of staphylococci. Gene expression changed after cultivation with IQ-238. Metabolic modelling did yield the adaptations of all central enzymes, including those not affected by significant gene expression changes. The data show that IQ-238 interferes with the carbohydrate metabolism in staphylococci. The data suggest that IQ-238 is a promising lead for antibiotic therapy against S. aureus infections. HG001 WT strain exposed to GB-AP-238 in rich medium

2015-04-30 | E-GEOD-33832 | biostudies-arrayexpress

Large-scale proteogenomics characterization of the Mycobacterium tuberculosis hidden proteome

Project description:Traditional genome annotation methods exclude Open Reading Frames shorter than 300 codons (smORFs), which leaves a substantial portion of the proteome overlooked. Proteogenomics is a multi-omics approach that merges genomics, transcriptomics and proteomics to identify proteoforms and unannotated proteins from Mass Spectrometry data. Here, we employed our recently developed proteogenomics pipeline to aid genome annotation and identify hundreds of novel microproteins encoded by smORFs in the genome of Mycobacterium tuberculosis (Mtb). To avoid limitations regarding sensitivity, we used 680 Mass Spectrometry experiments in a large-scale approach, which let us classify the findings by different degrees of confidence using our machine learning model. After integrating the results with RNA-Seq datasets, we explore the biological relevance of the novel sequences and show they are differentially expressed upon starvation and antibiotic treatment, and are co-expressed with many annotated genes that are vital for bacterial virulence. Moreover, some smORFs are located inside essential genomic segments and could be attractive targets for the development of new drugs. Altogether, our results should improve the current annotation of the proteome of Mtb and guide the following studies focusing on studying these microproteins thoroughly.

2025-05-06 | PXD042958 | Pride

Resource misallocation as a mediator of fitness costs in antibiotic resistance

Project description:Antimicrobial resistance (AMR) poses a threat to global health and the economy. Rifampicin resistant Mycobacterium tuberculosis accounts for a third of the global AMR burden. Gaining the upper hand on AMR requires a deeper understanding of the physiology of resistance. AMR often results in the erosion of normal cell function: a fitness cost. Identifying intervention points in the mechanisms underpinning the cost of resistance in M. tuberculosis could play a pivotal role in strengthening future treatment regimens. We used a collection of M. tuberculosis strains providing an evolutionary and phylogenetic snapshot of rifampicin resistance and subjected them to genome-wide transcriptomic and proteomic profiling to identify key perturbations of normal physiology. We found that a rifampicin resistance-conferring mutation in RpoB imparts considerable gene expression changes, many of which are mitigated by a compensatory mutation in RpoC. However, our data also provide evidence for pervasive epistasis: the same resistance mutation imposed a different fitness cost and functionally unrelated changes to gene expression in clinical strains from unrelated genetic backgrounds. Rather than functional changes in specific pathways, our data suggest that the fitness cost of rifampicin resistance stems from a misallocation of resources: the greater the departure from the wild type baseline proteome investment, the greater the fitness cost of rifampicin resistance in a given strain. We summarize these observations in the “Burden of Expression” hypothesis of fitness cost and provide evidence that it can be used for suppressing the emergence of rifampicin resistance.

2021-03-12 | PXD011568 | Pride

Transcriptional analysis of regulatory effects in Corynebacterium glutamicum and a derived (p)ppGpp0 mutant strain

Project description:The alarmone species ppGpp and pppGpp are an important part of bacterial physiology as they both coordinate the bacterial stress response to nutrient deficiency and also contribute to the maintenance of cell homeostasis. Recently, all components of the (p)ppGpp metabolism for the industrially relevant actinobacterial model organism Corynebacterium glutamicum could be functionally characterized by in vitro analysis and heterologous expression in the model system Escherichia coli. Based on these results, the strain C. glutamicum CR099 ΔrelΔrelSΔrelH is the first C. glutamicum (p)ppGpp0 strain available. The aim of this study was to investigate the effects of the alarmone species on transcriptome regulation in C. glutamicum by differential transcriptome analysis of the parental strain and the (p)ppGpp0 mutant. An RNAseq analysis of the early exponential growth phase was performed to analyze the (p)ppGpp basal level effects (Illumina TruSeq stranded mRNA libraries sequenced on Illumina HiSeq rapid mode 2 x 25nt PE). Due to the direct association of the alarmones with the bacterial stress response, the transcriptional response to the induction of a total starvation situation was investigated in form of a time series. Following an analysis of pooled replicates for 5 time points (Illumina TruSeq stranded mRNA libraries sequenced on Illumina HiSeq rapid mode 2 x 50nt PE), a detailed investigation was carried out for two stress exposure durations using three biological replicates per strain and time point each (Illumina TruSeq stranded mRNA libraries sequenced on Illumina HiSeq rapid mode 2 x 25nt PE).

2019-12-02 | E-MTAB-8070 | biostudies-arrayexpress

mRNA-Seq of Lemna minor exposed to different concentrations of sucralose against untreated control groups

Project description:The experiment investigates how the artificial sweetener sucralose affects gene expression in the teleost fish Danio rerio in order to derive mechanistic information relevant for environmental risk assessment. The main test including transcriptomics, was conducted with 10 µg/L and 100 mg/L as test concentrations. Whole plant tissue from each exposure group and corresponding controls was sampled after 7 days for RNA extraction, and poly(A)-enriched RNA was sequenced (paired-end, 150 bp) on an Illumina NovaSeq platform, followed by alignment to the Lemna minor reference genome and differential expression analysis using a DESeq2-based workflow with independent hypothesis weighting, data-driven log2 fold-change thresholds, and multiple-testing correction to define robust sets of differentially expressed genes per substance and concentration. Overrepresentation analysis of Gene Ontology terms using a common detected-gene background then mapped these gene-level changes to biological processes.

2026-04-30 | E-MTAB-16758 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data